Total Funding
17
59
Total FundingVenture - Series Unknown raised
Growth Score
-25 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
134338
OptMed is a biotech company that develops and commercializes biocompatible polymer and genitourinary therapeutic platforms.
Ervin Braun: CEO and DirectorPast Role: Frozen Foods Partners, Director- Alain Klapholz: COO & FounderPast Role: Ortec, Founder & VP Business Development
About the Company
OptMed develops and commercializes biocompatible polymer and genitourinary therapeutic platforms. Its biocompatible polymers platform serves for biosurgical adhesive and sealant, and industrial adhesive applications. The company’s and genitourinary therapeutics platform serves for the treatment of lower urinary tract conditions, including
overactive bladder and kidney stones. Its products include Devakor, a topical skin adhesive for surgical sutures.
OptMed was incorporated in 2007 and is based in Woodmere, New York.
